Search research articles
Contact Us
Filters
Showing results (51-60 of 129) with videos related to
Page
of 13
Sort By:
Nanotheranostics
|
May 11, 2021
Tracking adoptive T cell immunotherapy using magnetic particle imaging
Angelie Rivera-Rodriguez, Lan B Hoang-Minh, Andreina Chiu-Lam, et al.
Cancer Immunology, Immunotherapy : CII
|
July 20, 2007
EGFRvIII-targeted immunotoxin induces antitumor immunity that is inhibited in the absence of CD4+ and CD8+ T cells
Hidenobu Ochiai, Gary E Archer, James E Herndon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 2, 2018
Cross-talk between T Cells and Hematopoietic Stem Cells during Adoptive Cellular Therapy for Malignant Glioma
Tyler J Wildes, Adam Grippin, Kyle A Dyson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 19, 2018
RNA-Modified T Cells Mediate Effective Delivery of Immunomodulatory Cytokines to Brain Tumors
Fernanda Pohl-Guimarães, Changlin Yang, Kyle A Dyson, et al.
Virology Journal
|
March 30, 2021
Precision therapeutic targets for COVID-19
Zachary A Krumm, Grace M Lloyd, Connor P Francis, et al.
Journal of Neuroimmunology
|
December 2, 2006
Genetic analysis of intracranial tumors in a murine model of glioma demonstrate a shift in gene expression in response to host immunity
Chris A Learn, Peter M Grossi, Robert J Schmittling, et al.
Journal of Immunological Methods
|
September 9, 2008
Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines
Robert J Schmittling, Gary E Archer, Duane A Mitchell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2006
Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T cells in patients with malignant glioma reveals differential expression of the immunologic transcriptome compared with T cells from healthy volunteers
Chris A Learn, Peter E Fecci, Robert J Schmittling, et al.
Cancer Immunology Research
|
February 27, 2014
Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibody
Bryan D Choi, Patrick C Gedeon, James E Herndon, et al.
Oncoimmunology
|
May 8, 2015
Novel role of hematopoietic stem cells in immunologic rejection of malignant gliomas
Catherine Flores, Christina Pham, David Snyder, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 129) with videos related to
Sort By:
Page
of 13
Nanotheranostics
|
May 11, 2021
Tracking adoptive T cell immunotherapy using magnetic particle imaging
Angelie Rivera-Rodriguez, Lan B Hoang-Minh, Andreina Chiu-Lam, et al.
Cancer Immunology, Immunotherapy : CII
|
July 20, 2007
EGFRvIII-targeted immunotoxin induces antitumor immunity that is inhibited in the absence of CD4+ and CD8+ T cells
Hidenobu Ochiai, Gary E Archer, James E Herndon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 2, 2018
Cross-talk between T Cells and Hematopoietic Stem Cells during Adoptive Cellular Therapy for Malignant Glioma
Tyler J Wildes, Adam Grippin, Kyle A Dyson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 19, 2018
RNA-Modified T Cells Mediate Effective Delivery of Immunomodulatory Cytokines to Brain Tumors
Fernanda Pohl-Guimarães, Changlin Yang, Kyle A Dyson, et al.
Virology Journal
|
March 30, 2021
Precision therapeutic targets for COVID-19
Zachary A Krumm, Grace M Lloyd, Connor P Francis, et al.
Journal of Neuroimmunology
|
December 2, 2006
Genetic analysis of intracranial tumors in a murine model of glioma demonstrate a shift in gene expression in response to host immunity
Chris A Learn, Peter M Grossi, Robert J Schmittling, et al.
Journal of Immunological Methods
|
September 9, 2008
Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines
Robert J Schmittling, Gary E Archer, Duane A Mitchell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2006
Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T cells in patients with malignant glioma reveals differential expression of the immunologic transcriptome compared with T cells from healthy volunteers
Chris A Learn, Peter E Fecci, Robert J Schmittling, et al.
Cancer Immunology Research
|
February 27, 2014
Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibody
Bryan D Choi, Patrick C Gedeon, James E Herndon, et al.
Oncoimmunology
|
May 8, 2015
Novel role of hematopoietic stem cells in immunologic rejection of malignant gliomas
Catherine Flores, Christina Pham, David Snyder, et al.
Page
of 13